Liu Jun, Li Xiang, Yang Peng, He Yufeng, Hong Weilong, Feng Yawei, Ye Zhiqiang
Department of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
J Transl Med. 2025 Jan 6;23(1):15. doi: 10.1186/s12967-024-06032-7.
Acute respiratory distress syndrome (ARDS) is a life-threatening and heterogeneous disorder leading to lung injury. To date, effective therapies for ARDS remain limited. Sepsis is a frequent inducer of ARDS. However, the precise mechanisms underlying sepsis-induced ARDS remain unclear.
Here RNA methylation was detected by methylated RNA immunoprecipitation (MeRIP), RNA stability was determined by RNA decay assay while RNA antisense purification (RAP) was used to identify RNA-protein interaction. Besides, co-immunoprecipitation (Co-IP) was utilized to detect protein-protein interaction. Moreover, mice were injected with lipopolysaccharide (LPS) to establish sepsis-induced ARDS model in vivo.
This study revealed that long non-coding RNA (lncRNA) nuclear-enriched abundant transcript 1 (NEAT1) aggravated lung injury through suppressing angiotensin-converting enzyme 2 (ACE2) in sepsis-induced ARDS models in vitro and in vivo. Mechanistically, NEAT1 declined ACE2 mRNA stability through heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) in lipopolysaccharide (LPS)-treated alveolar type II epithelial cells (AT-II cells). Besides, NEAT1 destabilized ACE2 mRNA depending on RNA methylation by forming methylated NEAT1/hnRNPA2B1/ACE2 mRNA complex in LPS-treated AT-II cells. Moreover, lin-28 homolog A (LIN28A) improved NEAT1 stability whereas insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) augmented NEAT1 destabilization by associating with LIN28A to disrupt the combination of LIN28A and NEAT1 in LPS-treated AT-II cells. Nevertheless, hnRNPA2B1 increased NEAT1 stability by blocking the interaction between LIN28A and IGF2BP3 in LPS-treated AT-II cells.
These findings uncover mechanisms of sepsis-triggering ARDS and provide promising therapeutic targets for sepsis-induced ARDS.
急性呼吸窘迫综合征(ARDS)是一种危及生命的异质性疾病,可导致肺损伤。迄今为止,ARDS的有效治疗方法仍然有限。脓毒症是ARDS的常见诱因。然而,脓毒症诱导ARDS的精确机制仍不清楚。
本研究通过甲基化RNA免疫沉淀法(MeRIP)检测RNA甲基化,通过RNA降解试验测定RNA稳定性,同时利用RNA反义纯化法(RAP)鉴定RNA-蛋白质相互作用。此外,采用免疫共沉淀法(Co-IP)检测蛋白质-蛋白质相互作用。此外,给小鼠注射脂多糖(LPS)以在体内建立脓毒症诱导的ARDS模型。
本研究表明,在体外和体内脓毒症诱导的ARDS模型中,长链非编码RNA(lncRNA)核富集丰富转录本1(NEAT1)通过抑制血管紧张素转换酶2(ACE2)加重肺损伤。机制上,在脂多糖(LPS)处理的II型肺泡上皮细胞(AT-II细胞)中,NEAT1通过异质性核核糖核蛋白A2/B1(hnRNPA2B1)降低ACE2 mRNA稳定性。此外,在LPS处理的AT-II细胞中,NEAT1通过形成甲基化NEAT1/hnRNPA2B1/ACE2 mRNA复合物,依赖RNA甲基化使ACE2 mRNA不稳定。此外,在LPS处理的AT-II细胞中,lin-28同源物A(LIN28A)提高NEAT1稳定性,而胰岛素样生长因子2 mRNA结合蛋白3(IGF2BP3)通过与LIN28A结合破坏LIN28A与NEAT1的结合来增强NEAT1的去稳定化。然而,在LPS处理的AT-II细胞中,hnRNPA2B1通过阻断LIN28A与IGF2BP3之间的相互作用来增加NEAT1稳定性。
这些发现揭示了脓毒症引发ARDS的机制,并为脓毒症诱导的ARDS提供了有前景的治疗靶点。